Back to Studies Overview
The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be
| Study Name on ClinicalTrials.gov |
Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years |
| Study Drug | Inhaled Mannitol (Bronchitol) |
| Type of Study Drug | Restore Airway Surface Liquid |
| Study Title | A Randomised, Multicentre, Double-blind, Placebo-controlled, Crossover Trial Determining the Efficacy of Dry Powder Mannitol in Improving Lung Function in Subjects With Cystic Fibrosis Aged Six to Seventeen Years |
| Study Phase | 2 |
| Study Sponsor | Pharmaxis |
| Link on clinicaltrials.gov |
http://www.clinicaltrials.gov/ct2/show/NCT01883531 |
| Participating ECFS-CTN sites | Belgium: Leuven France: Lyon, Reims, Paris (Debré), Montpellier Germany : Frankfurt Italy: Milan, Rome, Verona The Netherlands: Rotterdam UK: Birmingham, London, Nottingham |
| Age |
6 Years to 17 Years |